Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry 'Revision: v3.6.3' was added to the record history, replacing the previous 'Revision: v3.6.2'. This reflects an update to the page's revision notes.SummaryDifference0.1%

- Check8 days agoChange DetectedThe history shows a new page revision entry (v3.6.2) added, replacing the previous v3.6.0, indicating an updated site version for the record history. This is a metadata change that updates the revision label rather than altering trial data.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history now includes a new addition stating 'No longer looking for participants,' signaling that recruitment for the study has ended. A new revision tag 'Revision: v3.6.0' was added, while the previous revision 'Revision: v3.5.5' was removed from the history.SummaryDifference0.3%

- Check30 days agoChange DetectedA new Revision: v3.5.5 appears in the history, replacing the previous Revision: v3.5.4. This update reflects a software release version change for the page rather than any changes to study data or user-facing content.SummaryDifference0.1%

- Check51 days agoChange DetectedVersion 23 (dated 2026-05-12) adds a new 'Study Status' entry to the Record History. This update records the trial's current status as part of the historical log.SummaryDifference0.4%

- Check72 days agoChange DetectedThis updates the displayed interface revision/version of the ClinicalTrials.gov record history page from v3.5.0 to v3.5.3 without changing the underlying study information.SummaryDifference0.1%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.